PMID- 39528076
OWN - NLM
STAT- MEDLINE
DCOM- 20241214
LR  - 20241214
IS  - 1873-5118 (Electronic)
IS  - 0301-0082 (Linking)
VI  - 243
DP  - 2024 Dec
TI  - CB(1) receptors in NG2 cells mediate cannabinoid-evoked functional myelin 
      regeneration.
PG  - 102683
LID - S0301-0082(24)00119-9 [pii]
LID - 10.1016/j.pneurobio.2024.102683 [doi]
AB  - Defects in myelin homeostasis have been reported in many neuropathological 
      conditions. Cannabinoid compounds have been shown to efficiently promote myelin 
      regeneration in animal models of demyelination. However, it is still unknown 
      whether this action relies mostly on a cell autonomous effect on 
      oligodendroglial-lineage-NG2 cells. By using conditional genetic mouse models, 
      here we found that cannabinoid CB(1) receptors located on NG2 cells are required 
      for oligodendroglial differentiation and myelin regeneration after demyelination. 
      Selective CB(1) receptor gene depletion in NG2 cells following toxin-induced 
      demyelination disrupted oligodendrocyte regeneration and functional remyelination 
      and exacerbated axonal damage. These deficits were rescued by pharmacological 
      blockade of the RhoA/ROCK/Cofilin pathway. Conversely, tetrahydrocannabinol 
      administration promoted oligodendrocyte regeneration and functional remyelination 
      in wild-type but not Ng2-CB(1)-deficient mice. Overall, this study identifies 
      CB(1) receptors as essential modulators of remyelination and support the 
      therapeutic potential of cannabinoids for promoting remyelination in neurological 
      disorders.
CI  - Copyright © 2024 Elsevier Ltd. All rights reserved.
FAU - Sánchez de la Torre, Aníbal
AU  - Sánchez de la Torre A
AD  - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain; 
      Department of Biochemistry and Molecular Biology, Complutense University, 
      Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid 
      28040, Spain.
FAU - Ezquerro-Herce, Sara
AU  - Ezquerro-Herce S
AD  - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain; 
      Department of Biochemistry and Molecular Biology, Complutense University, 
      Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid 
      28040, Spain.
FAU - Huerga-Gómez, Alba
AU  - Huerga-Gómez A
AD  - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain; 
      Department of Biochemistry and Molecular Biology, Complutense University, 
      Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid 
      28040, Spain.
FAU - Sánchez-Martín, Ester
AU  - Sánchez-Martín E
AD  - Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa 
      48940, Spain; Achucarro Basque Center for Neuroscience, Leioa 48940, Spain; IIS 
      Biobizkaia, Barakaldo 48903, Spain.
FAU - Chara, Juan Carlos
AU  - Chara JC
AD  - Achucarro Basque Center for Neuroscience, Leioa 48940, Spain; Centro de 
      Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
      (CIBERNED), Madrid 28049, Spain.
FAU - Matute, Carlos
AU  - Matute C
AD  - Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa 
      48940, Spain; Achucarro Basque Center for Neuroscience, Leioa 48940, Spain; 
      Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
      (CIBERNED), Madrid 28049, Spain.
FAU - Monory, Krisztina
AU  - Monory K
AD  - Institute of Physiological Chemistry, University Medical Center Mainz, Mainz 
      55128, Germany.
FAU - Mato, Susana
AU  - Mato S
AD  - Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa 
      48940, Spain; Achucarro Basque Center for Neuroscience, Leioa 48940, Spain; 
      Institute of Physiological Chemistry, University Medical Center Mainz, Mainz 
      55128, Germany.
FAU - Lutz, Beat
AU  - Lutz B
AD  - Institute of Physiological Chemistry, University Medical Center Mainz, Mainz 
      55128, Germany.
FAU - Guzmán, Manuel
AU  - Guzmán M
AD  - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain; 
      Department of Biochemistry and Molecular Biology, Complutense University, 
      Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid 
      28040, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades 
      Neurodegenerativas (CIBERNED), Madrid 28049, Spain.
FAU - Aguado, Tania
AU  - Aguado T
AD  - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain; 
      Department of Biochemistry and Molecular Biology, Complutense University, 
      Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid 
      28040, Spain. Electronic address: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="94e0f5f3e1f5f0fbd4e1f7f9baf1e7">[email&#160;protected]</a>.
FAU - Palazuelos, Javier
AU  - Palazuelos J
AD  - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain; 
      Department of Biochemistry and Molecular Biology, Complutense University, 
      Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid 
      28040, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades 
      Neurodegenerativas (CIBERNED), Madrid 28049, Spain. Electronic address: 
      <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="442e6a342528253e3121282b37043127296a2137">[email&#160;protected]</a>.
LA  - eng
PT  - Journal Article
DEP - 20241109
PL  - England
TA  - Prog Neurobiol
JT  - Progress in neurobiology
JID - 0370121
RN  - 0 (Receptor, Cannabinoid, CB1)
RN  - 7J8897W37S (Dronabinol)
RN  - 0 (Cannabinoids)
SB  - IM
MH  - Animals
MH  - *Receptor, Cannabinoid, CB1/metabolism
MH  - *Myelin Sheath/drug effects/metabolism
MH  - Mice
MH  - *Oligodendroglia/drug effects/metabolism
MH  - *Demyelinating Diseases/chemically induced/metabolism/drug therapy
MH  - *Remyelination/drug effects/physiology
MH  - Dronabinol/pharmacology
MH  - Cannabinoids/pharmacology
MH  - Mice, Inbred C57BL
MH  - Mice, Knockout
MH  - Nerve Regeneration/drug effects/physiology
OTO - NOTNLM
OT  - CB(1) receptor
OT  - Cannabinoid
OT  - Demyelination
OT  - NG2 cell
OT  - Remyelination
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2024/11/13 13:48
MHDA- 2024/12/15 00:42
CRDT- 2024/11/11 19:21
PHST- 2024/07/02 00:00 [received]
PHST- 2024/09/24 00:00 [revised]
PHST- 2024/10/28 00:00 [accepted]
PHST- 2024/12/15 00:42 [medline]
PHST- 2024/11/13 13:48 [pubmed]
PHST- 2024/11/11 19:21 [entrez]
AID - S0301-0082(24)00119-9 [pii]
AID - 10.1016/j.pneurobio.2024.102683 [doi]
PST - ppublish
SO  - Prog Neurobiol. 2024 Dec;243:102683. doi: 10.1016/j.pneurobio.2024.102683. Epub 
      2024 Nov 9.